BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6427361)

  • 1. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model.
    Döring G; Dalhoff A; Vogel O; Brunner H; Dröge U; Botzenhart K
    J Infect Dis; 1984 Apr; 149(4):532-7. PubMed ID: 6427361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].
    Döring G; Obernesser HJ; Botzenhart K
    Zentralbl Bakteriol A; 1981 Mar; 249(1):89-98. PubMed ID: 6791405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies of the pathogenesis of infections owing to Pseudomonas aeruginosa: elastase, an IgG protease.
    Holder IA; Wheeler R
    Can J Microbiol; 1984 Sep; 30(9):1118-24. PubMed ID: 6439405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alkaline protease and elastase in the adherence of Pseudomonas aeruginosa to WEHI cells.
    Trancassini M; Magni A; Ghezzi MC; Nazzari C; Brenciaglia MI; Filadoro F
    Microbiologica; 1989 Jul; 12(3):257-61. PubMed ID: 2506409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.
    Heck LW; Morihara K; Abrahamson DR
    Infect Immun; 1986 Oct; 54(1):149-53. PubMed ID: 3093382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of protease activity in human otitis media.
    Avidano MA; Cotter CS; Stringer SP; Schultz GS
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.
    Heck LW; Morihara K; McRae WB; Miller EJ
    Infect Immun; 1986 Jan; 51(1):115-8. PubMed ID: 3079727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence of Pseudomonas aeruginosa elastase deficient mutant.
    Trancassini M; Ghezzi MC; Magni A; Nazzari C; Brenciaglia MI
    Microbiologica; 1990 Apr; 13(2):97-100. PubMed ID: 2112680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases.
    Caballero AR; Moreau JM; Engel LS; Marquart ME; Hill JM; O'Callaghan RJ
    Anal Biochem; 2001 Mar; 290(2):330-7. PubMed ID: 11237336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro.
    Kharazmi A; Döring G; Høiby N; Valerius NH
    Infect Immun; 1984 Jan; 43(1):161-5. PubMed ID: 6317565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
    Bainbridge T; Fick RB
    J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.
    Kharazmi A; Høiby N; Döring G; Valerius NH
    Infect Immun; 1984 Jun; 44(3):587-91. PubMed ID: 6327528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
    Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K
    Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A
    J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.
    Pedersen BK; Kharazmi A
    Infect Immun; 1987 Apr; 55(4):986-9. PubMed ID: 3030937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LasA, alkaline protease and elastase in clinical strains of Pseudomonas aeruginosa: quantification by immunochemical methods.
    Coin D; Louis D; Bernillon J; Guinand M; Wallach J
    FEMS Immunol Med Microbiol; 1997 Jul; 18(3):175-84. PubMed ID: 9271168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
    Pillar CM; Hazlett LD; Hobden JA
    Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.